Barbara Duncan
Chairman at FUSN PHAR
Net worth: 640 873 $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lloyd Klickstein | M | 67 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 years |
| Andrea Corcoran | F | 61 | 11 years | |
| Jean-Pierre Sommadossi | M | 68 | 12 years | |
| Thomas Perone | M | 59 | 5 years | |
| Mark Dipaolo | M | 53 | 6 years | |
| Michael LaBarre | M | 60 | 16 years | |
| Odysseas Kostas | M | 49 | 7 years | |
| John Valliant | M | 54 | 10 years | |
| Rocco Venezia | M | 48 | 8 years | |
| Jeremy Levin | M | 70 | 10 years | |
| Mark Snyder | M | 57 | 2 years | |
| Nicole LaBrosse | F | 41 | 9 years | |
| Helen Torley | M | 61 | 10 years | |
| Connie Matsui | F | 70 | 18 years | |
| Jeffrey Henderson | M | 59 | 9 years | |
| Andrew Dickinson | M | 54 | 4 years | |
| Megan Alexander | F | - | - | |
| Bernadette Connaughton | F | 65 | 6 years | |
| Jacquelyn Sandell | F | - | 5 years | |
| Suzanne K. Wakamoto | F | - | 9 years | |
| Pablo Cagnoni | M | 60 | 5 years | |
| Christina Carlson | F | - | 4 years | |
| Kevin Fitzgerald | M | 56 | 3 years | |
| Jason Tardio | M | 47 | 5 years | |
| Polly Murphy | M | 59 | 4 years | |
| Maria Horga | M | 55 | 4 years | |
| Donald Bergstrom | M | 52 | 3 years | |
| Philina Lee | M | 47 | 3 years | |
| Jerome Adams | M | 49 | 3 years | |
| Eric Laub | M | - | 3 years | |
| Akiko Miyashita | F | 68 | 2 years | |
| Wayne Foster | M | 55 | 5 years | |
| Bruno Lucidi | M | 64 | 10 years | |
| Dirk Haasner | M | 59 | 8 years | |
| Bart Friedman | M | 79 | 9 years | |
| Jeffrey Rona | M | 55 | 5 years | |
| Tram Bui | F | - | 2 years | |
| Jules Haimovitz | M | 73 | 6 years | |
| Jonae R. Barnes | F | - | 3 years | |
| Franklin Berger | M | 74 | 5 years | |
| Steven Gannon | M | 62 | 4 years | |
| Mark Pruzanski | M | 56 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 years |
| Matthew Posard | M | 56 | 11 years | |
| Karen Bernstein | M | 71 | 9 years | |
| John Furey | M | 59 | 6 years | |
| Bruce Polsky | M | 70 | 10 years | |
| Brett Pletcher | M | 56 | 4 years | |
| Amanda Cray | F | - | - | |
| Robert Poole | M | 67 | 3 years | |
| Sarah Schlesinger | M | 64 | 6 years | |
| Manoj Malhotra | M | - | 1 years | |
| Toshiya Nishi | M | - | 1 years | |
| Todd F. Baumgartner | M | - | 3 years | |
| Mohit Rawat | M | - | 3 years | |
| Gavin Wood | M | 54 | 4 years | |
| Julia Tsai | M | - | 3 years | |
| Simon D. Kelner | M | 51 | 2 years | |
| Zhong Zhong | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael W. Aguiar | M | 57 | 13 years | |
| Matthew During | M | 67 | 5 years | |
| Kimberlee Drapkin | F | 55 | 10 years | |
| Cary Pfeffer | M | 61 | 8 years | |
| Brian Piper | M | 52 | 5 years | |
| Arnold Lippa | M | 77 |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 11 years |
| Michael R. Garone | M | 66 | 4 years | |
| George Bickerstaff | M | 68 | 6 years | |
| Richard Goodman | M | 75 | 19 years | |
| James Noble | M | 65 | 15 years | |
| Lorenzo M. Tallarigo | M | 74 | 6 years | |
| Perry Karsen | M | 69 | 7 years | |
| Timothy G. Daly | M | 52 | 6 years | |
| Richard Murray | M | 65 | 9 years | |
| Michael Cola | M | 64 | 7 years | |
| Harout Semerjian | M | 52 | - | |
| Jigar Raythatha | M | 47 | 8 years | |
| Mark Vignola | M | 47 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 6 years |
| Robert Iannone | M | 57 | 5 years | |
| Michael White | M | 72 | 19 years | |
| Claude Nicaise | M | 71 | 8 years | |
| John Leaman | M | 51 | 3 years | |
| Rafaèle Elisabeth Tordjman | M | 54 | 8 years | |
| Amit Rakhit | M | 54 | 5 years | |
| Robert Kamen | M | 79 | 10 years | |
| John Duncan Higgons | M | 69 | 7 years | |
| Bruce R. Lakefield | M | 80 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 4 years |
| Johan Rutger Christenson | M | 65 | 6 years | |
| Douglas Williams | M | 66 | 5 years | |
| Brian O'Callaghan | M | 54 | 3 years | |
| Chau Khuong | M | 48 | 4 years | |
| Heather Elizabeth Preston | M | 58 | 4 years | |
| Alastair Clemow | M | 72 | 10 years | |
| William Garrahan | M | 66 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 5 years |
| Yaron Werber | M | - | 3 years | |
| C. Dan Adams | M | 63 |
Louisiana State University
| 4 years |
| Glenn Sblendorio | M | 68 | 9 years | |
| James Healy | M | 58 | 8 years | |
| Isaac Blech | M | 73 | 6 years | |
| Jeffrey Allen Ferrell | M | 49 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 7 years |
| Klaus Veitinger | M | 62 | 4 years | |
| Lynn Wick | F | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 78 | 78.00% |
| Canada | 11 | 11.00% |
| Israel | 5 | 5.00% |
| United Kingdom | 4 | 4.00% |
| Switzerland | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barbara Duncan
- Personal Network
